Verition Fund Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-248,837
| Closed | -$6.62M | – | 3229 |
|
|
2025
Q4 | $6.2M | Sell |
248,837
-117,055
| -32% | -$2.95M | 0.02% | 728 |
|
|
2025
Q3 | $9.32M | Buy |
365,892
+46,516
| +15% | +$1.15M | 0.04% | 568 |
|
|
2025
Q2 | $7.74M | Sell |
319,376
-32,992
| -9% | -$769K | 0.03% | 695 |
|
|
2025
Q1 | $8.93M | Buy |
352,368
+248,509
| +239% | +$6.5M | 0.04% | 511 |
|
|
2024
Q4 | $2.76M | Sell |
103,859
-70,086
| -40% | -$1.9M | 0.01% | 1340 |
|
|
2024
Q3 | $5.03M | Buy |
173,945
+49,011
| +39% | +$1.43M | 0.03% | 851 |
|
|
2024
Q2 | $3.5M | Sell |
124,934
-631
| -0.5% | -$17.4K | 0.02% | 934 |
|
|
2024
Q1 | $3.48M | Sell |
125,565
-21,762
| -15% | -$604K | 0.02% | 903 |
|
|
2023
Q4 | $4.24M | Buy |
147,327
+13,819
| +10% | +$418K | 0.03% | 502 |
|
|
2023
Q3 | $4.43M | Buy |
133,508
+36,039
| +37% | +$1.27M | 0.05% | 489 |
|
|
2023
Q2 | $3.58M | Buy |
97,469
+9,215
| +10% | +$359K | 0.05% | 455 |
|
|
2023
Q1 | $3.6M | Buy |
88,254
+14,689
| +20% | +$634K | 0.05% | 479 |
|
|
2022
Q4 | $3.77M | Sell |
73,565
-79,966
| -52% | -$3.83M | 0.06% | 411 |
|
|
2022
Q3 | $6.72M | Buy |
153,531
+103,397
| +206% | +$5.02M | 0.08% | 310 |
|
|
2022
Q2 | $2.63M | Sell |
50,134
-1,038
| -2% | -$52.9K | 0.05% | 521 |
|
|
2022
Q1 | $2.65M | Buy |
51,172
+46,672
| +1,037% | +$2.42M | 0.03% | 761 |
|
|
2021
Q4 | $266K | Sell |
4,500
-17,331
| -79% | -$859K | ﹤0.01% | 2060 |
|
|
2021
Q3 | $939K | Buy |
21,831
+4,691
| +27% | +$208K | 0.01% | 956 |
|
|
2021
Q2 | $671K | Buy |
+17,140
| New | +$667K | 0.01% | 964 |
|
|
2021
Q1 | – | Sell |
-23,482
| Closed | -$864K | – | 1720 |
|
|
2020
Q4 | $864K | Buy |
23,482
+10,566
| +82% | +$388K | 0.01% | 538 |
|
|
2020
Q3 | $450K | Sell |
12,916
-64,477
| -83% | -$2.26M | 0.01% | 614 |
|
|
2020
Q2 | $2.4M | Buy |
+77,393
| New | +$2.63M | 0.08% | 196 |
|
|
2020
Q1 | – | Sell |
-57,250
| Closed | -$2.13M | – | 945 |
|
|
2019
Q4 | $2.13M | Buy |
57,250
+36,315
| +173% | +$1.29M | 0.04% | 260 |
|
|
2019
Q3 | $714K | Sell |
20,935
-10,179
| -33% | -$370K | 0.02% | 507 |
|
|
2019
Q2 | $1.28M | Buy |
+31,114
| New | +$1.24M | 0.04% | 355 |
|
|
2018
Q3 | – | Sell |
-28,353
| Closed | -$976K | – | 1406 |
|
|
2018
Q2 | $976K | Sell |
28,353
-2,002
| -7% | -$68.4K | 0.06% | 417 |
|
|
2018
Q1 | $1.02M | Buy |
+30,355
| New | +$1.04M | 0.08% | 353 |
|
|
2017
Q1 | – | Sell |
-30,117
| Closed | -$928K | – | 1402 |
|
|
2016
Q4 | $928K | Buy |
30,117
+19,856
| +194% | +$606K | 0.08% | 292 |
|
|
2016
Q3 | $330K | Buy |
+10,261
| New | +$343K | 0.04% | 729 |
|
|
2016
Q2 | – | Sell |
-9,645
| Closed | -$271K | – | 1009 |
|
|
2016
Q1 | $271K | Buy |
9,645
+1,075
| +13% | +$30.7K | 0.04% | 517 |
|
|
2015
Q4 | $262K | Sell |
8,570
-4,078
| -32% | -$128K | 0.05% | 333 |
|
|
2015
Q3 | $377K | Sell |
12,648
-131
| -1% | -$4.2K | 0.1% | 273 |
|
|
2015
Q2 | $407K | Buy |
+12,779
| New | +$416K | 0.07% | 238 |
|
|
2014
Q4 | – | Sell |
-24,656
| Closed | -$692K | – | 587 |
|
|
2014
Q3 | $692K | Buy |
24,656
+5,817
| +31% | +$163K | 0.1% | 166 |
|
|
2014
Q2 | $531K | Buy |
+18,839
| New | +$537K | 0.06% | 247 |
|
|
2014
Q1 | – | Sell |
-47,442
| Closed | -$1.38M | – | 617 |
|
|
2013
Q4 | $1.38M | Buy |
47,442
+30,280
| +176% | +$881K | 0.25% | 72 |
|
|
2013
Q3 | $467K | Buy |
+17,162
| New | +$467K | 0.07% | 225 |
|
Other funds holding PFE
VCM
VPM
Verition Fund Management's PFE Position: Q1 2026 in Review
Verition Fund Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 248,837 shares — an estimated $6.62M sold.
Verition Fund Management first reported a position in PFE in Q3 2013 and held it in 37 quarters. The position peaked at $9.32M in Q3 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Verition Fund Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Verition Fund Management sold 248,837 Pfizer shares in Q1 2026, an estimated $6.62M.
- Verition Fund Management first reported a position in Pfizer in Q3 2013 and held it in 37 quarters.
- Verition Fund Management's Pfizer position peaked at $9.32M in Q3 2025.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.